Effects of transforming growth factor-β1 on human vocal fold fibroblasts

Annals of Otology, Rhinology and Laryngology

Volumn 118, Issue 3, 2009, Pages 218-226

  Branski, Ryan C ^a,b,c   Barbieri, Silvia S ^d,g   Weksler, Babette B ^d   Saltman, Benjamin ^a,c   Krishna, Priya ^e,f   Kraus, Dennis H ^a,b   Broadbelt, Nalini V ^c   Chen, Jie ^a,c   Poppas, Dix P ^c   Felsen, Diane ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Otorhinolaryngology ^*

^c Institute for Pediatric Urology   (United States)

^d Division of Hematology and Medical Oncology

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

Fibrosis; Transforming growth factor; Vocal fold; Voice

Indexed keywords

COLLAGEN; LENTIVIRUS VECTOR; MESSENGER RNA; SIGNAL PEPTIDE; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VIRUS LARGE T ANTIGEN;

ADULT; ARTICLE; AUTOCRINE EFFECT; CASE REPORT; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROSIS; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; SCAR FORMATION; SIMIAN VIRUS 40; VOCAL CORD; VOCAL FOLD FIBROSIS;

EID: 62449152333     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940911800310     Document Type: Article

References (42)

1. Wu G, Chen YG, Ozdamar B, et al. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science 2000;287:92-7.
2. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004;18:816-27.
3. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynck R. Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol 1993;120:253-60.
4. Ignotz RA, Endo T, Massagué J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 1987;262:6443-6.
5. Laiho M, Saksela O, Keski-Oja J. Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem 1987;262:17467-74.
6. Roberts AB, Thompson NL, Heine U, Flanders C, Sporn MB. Transforming growth factor-beta: possible roles in carcinogenesis. Br J Cancer 1988;57:594-600.
7. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000;14:627-44.
8. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92.
9. Jonsson JR, Clouston AD, Ando Y, et al. Angiotensinconverting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001;121:148-55.
10. Duflo SM, Thibeault SL, Li W, Smith ME, Schade G, Hess MM. Differential gene expression profiling of vocal fold polyps and Reinke's edema by complementary DNA microarray. Ann Otol Rhinol Laryngol 2006;115:703-14.
11. Lim X, Tateya I, Tateya T, Muñoz-Del-Rio A, Bless DM. Immediate inflammatory response and scar formation in wounded vocal folds. Ann Otol Rhinol Laryngol 2006;115:921-9.
12. Hirano S, Bless D, Heisey D, Ford C. Roles of hepatocyte growth factor and transforming growth factor β1 in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope 2003;113:144-8.
13. Hirano S, Bless DM, Heisey D, Ford CN. Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2003;112:617-24.
14. Hirano S, Bless DM, Massey RJ, Hartig GK, Ford CN. Morphological and functional changes of human vocal fold fibroblasts with hepatocyte growth factor. Ann Otol Rhinol Laryngol 2003;112:1026-33.
15. Hirano S, Bless DM, Nagai H, et al. Growth factor apy for vocal fold scarring in a canine model. Ann Oto Laryngol 2004;113:777-85.
16. Hirano S, Bless DM, Rousseau B, et al. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope 2004;114:548-56.
17. Kitahara S, Masuda Y, Kitagawa Y. Vocal fold injury following endotracheal intubation. J Laryngol Otol 2005;119:8257.
18. Ding H, Gray SD. Senescent expression of genes cod ing collagens, collagen degrading metalloproteinases, and tissue inhibitors of metalloproteinases in rat vocal folds: comparison with skin and lungs. J Gerontol A Biol Sci Med Sci 2001;56:B145-B152
19. Ding H, Gray SD. Senescent expression of genes coding tropoelastin, elastase, lysyl oxidase, and tissue inhibitors of metalloproteinases in rat vocal folds: comparison with skin and lungs. J Speech Lang Hear Res 2001;44:317-26.
20. Thibeault SL, Li W, Gray SD, Chen Z. Instability of extracellular matrix gene expression in primary cell culture fibroblasts from human vocal fold lamina propria and tracheal scar. Ann Otol Rhinol Laryngol 2002;111:8-14.
21. Ylitalo R, Baugh A, Li W, Thibeault S. Effect of acid and pepsin on gene expression in laryngeal fibroblasts. Ann Otol Rhinol Laryngol 2004;113:866-71.
22. Lundberg AS, Randell SH, Stewart SA, et al. Immortalization and transformation of primary airway epithelial cells by gene transfer. Oncogene 2002;21:4577-86.
23. Davies BR, Steele IA, Edmondson RJ, et al. Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen. Exp Cell Res 2003;288:390-402.
24. Kudo Y, Hiraoka M, Kitagawa S, et al. Establishment of human cementifying fibroma cell lines by transfection with temperature-sensitive simian virus-40 T-antigen gene and hTERT gene. Bone 2002;30:712-7.
25. Weksler BB, Subileau EA, Perriére N, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005;19:1872-4.
26. Zennou V, Serguera C, Sarkis C, et al. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol 2001;19:446-50.
27. Sirven A, Ravet E, Charneau P, et al. Enhanced transgene expression in cord blood CD34(+)derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 2001;3:438-8.
28. Giannini C, Morosan S, Tralhao JG, et al. A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector. Hepatology 2003;38:114-22.
29. Buchet D, Serguera C, Zennou V, Charneau P, Mallet J. Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system. Mol Cell Neurosci 2002;19:389-401.
30. Kellner D, Chen J, Richardson I, et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. J Urol 2006;176:806-12.
31. Sandulache VC, Dohar JE, Hebda PA. Adult-fetal fibroblast interactions: effects on cell migration and implications for cell transplantation. Cell Transplant 2005;14:331-7.
32. El Chaar M, Chen J, Seshan SV, et al. Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 2007;292:F1291-F1301.
33. Branski RC, Rosen CA, Verdolini K, Hebda PA. Acute vocal fold wound healing in a rabbit model. Ann Otol Rhinol Laryngol 2005;114:19-24.
34. Thibeault SL, Gray SD, Bless DM, Chan RW, Ford CN. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002;16:96-104.
35. Liu X, Hu H, Yin JQ. Therapeutic strategies against TGFbeta signaling pathway in hepatic fibrosis. Liver Int 2006;26:8-22.
36. Sandulache VC, Parekh A, Li-Korotky HS, Dohar JE, Hebda PA. Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: implication for wound healing. Wound Repair Regen 2006;14:633-43.
37. Strick-Marchand M, Morosan S, Charneau P, Kremsdorf D, Weiss MC. Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes. Proc Natl Acad Sci USA 2004;101:8360-5.
38. Mordelet E, Kissa K, Calvo CF, et al. Brain engraftment of autologous macrophages transduced with a lentiviral flap vector: an approach to complement brain dysfunctions. Gene Ther 2002;9:46-52.
39. Hakenjos L, Bamberg M, Rodemann H. TGF-β1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol 2000;76:503-9.
40. Martin M, Lefaix J, Delanian S. TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 2000;47:277-90.
41. de Gouville AC, Boullay V, Krysa G, et al. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol 2005;145:166-77.
42. Miyajima A, Chen J, Lawrence C, et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000;58:2301-13.